RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 2014;134(2):415–420

PEDIATRICS ◽  
2014 ◽  
Vol 134 (6) ◽  
pp. 1221.1-1221 ◽  
Sign in / Sign up

Export Citation Format

Share Document